Top Markets
Coin of the day
GSK plc GSK plc

GSK plc

GSK
주식 순위 #9382
GSK plc is a global pharmaceutical and healthcare company, deeply involved in... GSK plc is a global pharmaceutical and healthcare company, deeply involved in the research, development, production, and commercialization of a diverse range of medicinal and wellness products. Its operations span the United Kingdom, the United States, and numerous other international markets. The company structures its operations across four primary divisions: Pharmaceuticals, Pharmaceutical R&D, Vaccines, and Consumer Healthcare. Within its Pharmaceuticals segment, GSK provides treatments addressing a wide array of therapeutic areas. These include respiratory conditions, HIV, immuno-inflammatory diseases, oncology, viral infections, central nervous system disorders, cardiovascular and urogenital health, metabolic imbalances, bacterial infections, and dermatological issues. The Consumer Healthcare division offers products across categories such as wellness, oral hygiene, nutritional supplements, and skin health. These consumer offerings come in a variety of formats, including oral dosage forms (e.g., tablets, syrups, lozenges, gummies, soft chews, effervescents), topical applications (e.g., gels, creams, patches, lip balms), nasal sprays, and a comprehensive range of oral hygiene products (e.g., toothpastes, mouthwashes, denture care items), alongside other specialized formulations like infant drops and wipes. GSK actively engages in various collaborative ventures. Its collaboration agreements include partnerships with 23andMe, Lyell Immunopharma, Inc., Novartis, Sanofi SA, Surface Oncology, Progentec Diagnostics, Inc., Alector, Inc., and CureVac AG. Additionally, the company maintains strategic alliances with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. Originally established in 1715, the company operated under the name GlaxoSmithKline plc until its rebranding to GSK plc in May 2022. Its corporate headquarters are situated in Brentford, United Kingdom.
주가
$25.28
마지막 동기화: 2026-09-18
시가총액
$1.01B
변동 (1일)
-2.29%
변동 (1년)
-37.84%
국가
GB
거래 GSK plc (GSK)

카테고리

GSK plc (GSK)의 EPS
June 2026 기준 EPS TTM: $3.27
GSK plc의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 $3.27입니다. 2024년 말에는 회사의 EPS가 $1.58였으며, 이는 2023년의 EPS $3.11와 감소입니다.
GSK plc의 EPS 기록 (2000 ~ 2026)
매년 말의 EPS
연도 EPS 변화
2026 (TTM) $3.27 -11.98%
2025 $3.71 134.74%
2024 $1.58 -49.10%
2023 $3.11 5.22%
2022 $2.95 -20.32%
2021 $3.70 -5.92%
2020 $3.94 26.89%
2019 $3.10 32.40%
2018 $2.34 122.33%
2017 $1.05 77.94%
2016 $0.59 -90.78%
2015 $6.42 186.38%
2014 $2.24 -51.96%
2013 $4.67 25.18%
2012 $3.73 -8.24%
2011 $4.07 226.52%
2010 $1.25 -71.71%
2009 $4.40 35.82%
2008 $3.24 -31.08%
2007 $4.70 0.76%
2006 $4.67 31.64%
2005 $3.55 8.50%
2004 $3.27 -5.77%
2003 $3.47 29.66%
2002 $2.67 45.99%
2001 $1.83 -27.83%
2000 $2.54 0.00%
유사 기업 또는 경쟁사의 EPS
회사 EPS EPS 차이 국가
$29.85 814.05%
US
$8.65 164.87%
US
$3.55 8.71%
US
$20.39 524.34%
CH
$1.26 -61.42%
US